ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 136 filers reported holding ALLAKOS INC in Q1 2022. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,332,000 | – | 233,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 4,887,932 | $517,485,000 | 86.88% |
| Fairmount Funds Management LLC | 175,362 | $18,566,000 | 6.75% |
| Redmile Group, LLC | 2,131,796 | $225,693,000 | 3.94% |
| Samsara BioCapital, LLC | 172,089 | $18,219,000 | 2.86% |
| Samsara BioCapital, LLC | 168,200 | $17,807,000 | 2.79% |
| NEA Management Company, LLC | 2,164,704 | $229,177,000 | 2.72% |
| Ghost Tree Capital, LLC | 85,000 | $8,999,000 | 2.63% |
| Sante Capital Fund, LP | 19,258 | $2,039,000 | 1.88% |
| Ikarian Capital, LLC | 150,800 | $15,964,000 | 1.12% |
| Eventide Asset Management | 630,000 | $66,698,000 | 0.88% |